Exam 3 Review: Fed State Protein Metabolism through Fasted State

0.0(0)
Studied by 0 people
call kaiCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/99

flashcard set

Earn XP

Description and Tags

Comprehensive vocabulary flashcards reviewing fed-state protein metabolism through fasted-state metabolic regulations, pathways, transporters, and calculations for Exam 3.

100 Terms

1
New cards

Gluconeogenesis Induction Timing

Anabolic pathway turned ON during a prolonged fast of at least 18–20 hrs18\text{--}20\text{ hrs} since the last meal, requiring high rates of fatty acid oxidation to proceed.

2
New cards

Pyruvate Carboxylase

The first enzyme in gluconeogenesis that converts pyruvate to oxaloacetate; requires acetyl-CoA as its obligatory allosteric activator.

3
New cards

Fasting Respiratory Exchange Ratio (RER)

An RER value close to 0.70.7, which reflects high rates of fatty acid oxidation meeting cellular ATP demand during prolonged fasting.

4
New cards

Glycerol (Gluconeogenic Substrate)

Three-carbon backbone released from adipose triglyceride breakdown that enters gluconeogenesis by being converted into glycerol 3-phosphate.

5
New cards

Lactate (Gluconeogenic Substrate)

Non-carbohydrate carbon source easily converted back into pyruvate by the enzyme lactate dehydrogenase to enter gluconeogenesis.

6
New cards

Amino Acid Carbon Skeletons (Gluconeogenesis)

Substrates that enter gluconeogenesis as pyruvate or TCA cycle intermediates, which are converted to oxaloacetate and subsequently synthesized into glucose.

7
New cards

Glucose-6-Phosphate Dehydrogenase

The primary regulated enzyme of the pentose phosphate pathway that produces NADPH.

8
New cards

6-Phosphogluconate Dehydrogenase

The secondary enzyme of the pentose phosphate pathway that generates NADPH.

9
New cards

Malic Enzyme

A standalone enzyme that provides an alternative cellular pathway to produce NADPH.

10
New cards

Cholesterol Synthesis (NADPH Requirement)

An anabolic biosynthetic pathway that requires reducing equivalents from NADPH to build cholesterol molecules.

11
New cards

De Novo Fatty Acid Synthesis (NADPH Requirement)

A pathway active in the fed state that requires NADPH as an electron donor to synthesize new fatty acids from acetyl-CoA.

12
New cards

Steroid Hydroxylase Reactions

Enzymatic reactions that utilize NADPH to convert cholesterol into steroid hormones, including estrogen, progesterone, and aldosterone.

13
New cards

NADPH Oxidase Reactions

Enzymatic reactions that utilize NADPH to generate reactive oxygen species.

14
New cards

Glutathione Reductase

An enzyme that requires NADPH to reduce oxidized glutathione back into its active, protective reduced form.

15
New cards

Tetrahydrofolate Conversion

The metabolic reaction that uses NADPH to convert folate into its bioactive coenzyme form, tetrahydrofolate.

16
New cards

Nitric Oxide Synthesis

The enzymatic synthesis of nitric oxide from amino acid precursors, which requires NADPH as an essential cofactor.

17
New cards

Protein Turnover

The continuous process in which body proteins are continually degraded and resynthesized based on metabolic needs.

18
New cards

Nonprotein Amino Acid Derivatives

Nitrogen-containing compounds synthesized from amino acids whose production will always occur regardless of nutritional state.

19
New cards

Stomach Protein Turnover Rate

Approximately 40%/day40\%/\text{day}, representing the highest turnover rate among listed tissues due to high transcription and translation activity.

20
New cards

Esophagus Protein Turnover Rate

Approximately 30%/day30\%/\text{day}, representing the second highest rate of tissue protein turnover.

21
New cards

Liver Protein Turnover Rate

Approximately 20%/day20\%/\text{day}, reflecting rapid synthesis and degradation of regulatory and secretory proteins.

22
New cards

Colon Protein Turnover Rate

Approximately 10%/day10\%/\text{day}, representing an intermediate rate of digestive tract protein turnover.

23
New cards

Lymphocyte Protein Turnover Rate

Approximately 7%/day7\%/\text{day}, reflecting the protein turnover rate of circulating immune cells.

24
New cards

Heart Protein Turnover Rate

Approximately 5%/day5\%/\text{day}, representing steady protein turnover in cardiac muscle.

25
New cards

Skeletal Muscle Protein Turnover Rate

Approximately 1–2%/day1\text{--}2\%/\text{day}, representing the lowest tissue rate due to low rates of cell replication.

26
New cards

Limiting Amino Acid Theory

The principle stating that if just one type of amino acid is missing from the amino acid pool, protein synthesis will completely stop.

27
New cards

Limiting Amino Acid

The amino acid present in the smallest quantity within the amino acid pool; it can be any amino acid and is not always an essential one.

28
New cards

Hexosamine Biosynthetic Pathway

A nutrient-sensing pathway upregulated in an overfed state without energy demand that requires proteins, glucose, lipid-derived acetyl-CoA, energy, and nucleotides.

29
New cards

O-GlcNAc (N-Acetylglucosamine)

The product of the hexosamine biosynthetic pathway that attaches to proteins and enzymes via covalent bonds as a post-translational modification.

30
New cards

O-GlcNAcase (OGA)

The specific enzyme responsible for removing N-acetylglucosamine (O-GlcNAc) from proteins.

31
New cards

O-GlcNAc Transferase (OGT)

The specific enzyme responsible for adding N-acetylglucosamine (O-GlcNAc) to target proteins.

32
New cards

Overfed State Metabolic Upregulations

Simultaneous upregulation of de novo fatty acid synthesis, glycerol synthesis, triglyceride synthesis, and the hexosamine biosynthetic pathway in conditions of nutrient excess.

33
New cards

Catecholamines

Hormones released from the adrenal medulla during stress, exercise, or fasting that bind to adrenergic receptors on target tissues like adipocytes.

34
New cards

Beta-Adrenergic Receptors (Adipocyte)

Receptors that engage a stimulatory G-protein to activate adenylyl cyclase and PKA, turning lipolysis and glycogenolysis ON and making cells more lipolytically active.

35
New cards

Adenylyl Cyclase (AC)

Enzyme activated downstream of beta-adrenergic receptor stimulatory G-proteins that converts ATP into cAMP.

36
New cards

Protein Kinase A (PKA) Lipolytic Targets

Kinase activated by cAMP that phosphorylates CGI-58, hormone-sensitive lipase (HSL), adipose triglyceride lipase (ATGL), and perilipin.

37
New cards

Perilipin

Lipid droplet regulatory protein that binds CGI-58 when unphosphorylated and releases CGI-58 upon PKA phosphorylation to enable lipolysis.

38
New cards

CGI-58

Co-regulatory protein released from phosphorylated perilipin that binds to ATGL and increases its enzymatic activity.

39
New cards

Adipose Triglyceride Lipase (ATGL)

Lipolytic enzyme that hydrolyzes triglycerides to diglycerides; activated when phosphorylated and associated with CGI-58.

40
New cards

Hormone-Sensitive Lipase (HSL)

Lipolytic enzyme that hydrolyzes diglycerides to monoglycerides; active when phosphorylated by PKA and allosterically inhibited by fatty acyl-CoAs.

41
New cards

Monoacylglycerol Lipase (MAGL)

Enzyme that converts monoglycerides to glycerol and free fatty acids; it is not regulated via phosphorylation.

42
New cards

Adipocyte Glycerol Kinase Deficiency

The absence of glycerol kinase in adipocytes, preventing rephosphorylation of glycerol to glycerol-3-phosphate and necessitating free glycerol export to the liver.

43
New cards

Alpha-Adrenergic Receptors (Adipocyte)

Receptors that engage an inhibitory G-protein to block adenylyl cyclase, preventing cAMP generation, halting PKA phosphorylation, and turning lipolysis OFF.

44
New cards

Beta-Cell Anaplerotic Reactions

Uptake of amino acids like leucine and glutamine that replenish TCA cycle intermediates, increasing ATP generation and raising the ATP:ADP ratio.

45
New cards

Beta-Cell ATP:ADP Ratio Mechanism

An elevated ATP:ADP ratio closes ATP-sensitive K+K^+ channels, preventing K+K^+ efflux, causing membrane depolarization, Ca2+Ca^{2+} entry, and insulin secretion.

46
New cards

ATP-Sensitive K+K^+ Channels

Potassium channels in pancreatic beta cells that close in response to high ATP, preventing K+K^+ transport and initiating cell membrane depolarization.

47
New cards

Na+Na^+-Dependent Amino Acid Co-Transport

Entry of neutral amino acids (such as alanine and proline) into beta cells alongside positively charged Na+Na^+ ions, causing membrane depolarization and insulin exocytosis.

48
New cards

Cationic Amino Acid Transport (Beta Cells)

Direct influx of positively charged amino acids (arginine and lysine) carrying net positive charge into cytosol, raising membrane potential to trigger insulin release.

49
New cards

Voltage-Gated Ca2+Ca^{2+} Channels (Beta Cells)

Membrane channels opened by depolarization that allow extracellular Ca2+Ca^{2+} influx, triggering exocytosis of insulin secretory granules.

50
New cards

Leucine (Muscle Signaling)

An essential amino acid that enters lysosomes to trigger the intracellular signaling cascade that initiates muscle protein synthesis.

51
New cards

RagA GTPase

G-protein that loads with GTP inside the lysosome to translocate mTORC1 from cytosol to the lysosomal surface; in its GDP-bound form, it inactivates mTOR.

52
New cards

Lysosome (mTOR Signaling Hub)

The essential organellar platform where amino acid signaling concentrates and activates mTORC1.

53
New cards

Maximal Muscle Protein Synthesis Stimuli

The combined, additive effect of amino acids, insulin, and IGF acting together to achieve maximum muscle protein synthesis.

54
New cards

mTOR Catabolic Targets

Master regulatory kinase that stimulates protein synthesis and inhibits protein degradation pathways (ubiquitin-proteasome pathway and autophagy-lysosomal system).

55
New cards

Ubiquitin-Proteasome and Autophagy-Lysosomal Systems

The two primary protein degradation pathways inhibited by active mTOR, which become active during fasting and prolonged fasting (24–48 hrs24\text{--}48\text{ hrs}).

56
New cards

PI3K/Akt Pathway (Fed State Signaling)

Downstream insulin signaling cascade in the fed state that blocks TSC, allowing Rheb-GTP to activate protein translation.

57
New cards

Tuberous Sclerosis Complex (TSC)

Regulatory complex that blocks Rheb-GTP; inhibited by insulin via Akt, but phosphorylated and activated by AMPK to shut off protein synthesis.

58
New cards

Rheb-GTP

G-protein that provides the necessary energy for protein translation when liberated from TSC inhibition.

59
New cards

AMP-Activated Protein Kinase (AMPK)

Energy sensor activated during low nutrient/energy states when the AMP:ATP ratio is high, acting to turn energy-expensive synthesis pathways OFF.

60
New cards

AMPK Activation Mechanisms

Direct allosteric activation by elevated AMP when ATP decreases, and covalent phosphorylation by PKA downstream of glucagon and catecholamines.

61
New cards

AMPK Regulation of TSC and mTOR

Active AMPK phosphorylates and activates TSC (blocking Rheb) and directly phosphorylates and inhibits mTOR to halt protein synthesis.

62
New cards

Fasted State Lipolysis

Metabolic pathway turned ON in the fasted state; fatty acids become the primary substrate for energy.

63
New cards

Fasted State Beta-Oxidation

Metabolic pathway turned ON in the fasted state that breaks fatty acid molecules down in mitochondria and cytosol to generate ATP.

64
New cards

Regular Fast Glycogenolysis

Pathway turned ON during a regular fast where liver glycogen is broken down into glucose to maintain blood glucose homeostasis.

65
New cards

Prolonged Fast Gluconeogenesis

Anabolic pathway turned ON in a prolonged fast (≥18–20 hrs\ge 18\text{--}20\text{ hrs}) where the body synthesizes new glucose from non-carbohydrate carbon sources.

66
New cards

Ketone Bodies

Circulating energy compounds (acetoacetate, beta-hydroxybutyrate, and acetone) synthesized from acetyl-CoA in liver mitochondria during a prolonged fast.

67
New cards

Cortisol (Prolonged Fast)

Hormone turned ON during a prolonged fast (24–48 hrs24\text{--}48\text{ hrs}) that actively drives bodily proteolysis, accompanied by an active urea cycle.

68
New cards

Fasting Circulating Lipoproteins

Lipoproteins found circulating in the blood during the fasted state, specifically VLDLs and LDLs.

69
New cards

GLUT 1 Transporter

Low-KmK_m glucose transporter expressed in almost all cells that provides basal glucose uptake and serves as the major active GLUT in the fasted state.

70
New cards

GLUT 4 Transporter

Insulin-stimulated glucose transporter housed intracellularly that is not active or present on the cell surface in the fasted state.

71
New cards

GLUT 2 Transporter

High-KmK_m glucose transporter that is NOT active for glucose uptake in the fasted state.

72
New cards

GLUT 3 Transporter

High-affinity glucose transporter expressed in the brain that is always active to ensure continuous glucose supply.

73
New cards

Albumin (Fatty Acid Transport)

Blood protein that binds and transports free fatty acids liberated from adipose lipolysis to target tissues like muscle and liver.

74
New cards

FATP and FABP Transporters

Fatty acid transport proteins present and active on the muscle cell membrane in the fasted state to import free fatty acids into cytosol.

75
New cards

FAT/CD36 Transporter

Insulin-stimulated fatty acid transporter that is recessed from the plasma membrane and sequestered intracellularly in the fasted state.

76
New cards

Carnitine Shuttle System

The key regulatory transport mechanism required for long-chain fatty acids to cross the mitochondrial membrane for beta-oxidation.

77
New cards

Carnitine Palmitoyltransferase 1 (CPT1)

Outer mitochondrial enzyme that removes CoA and attaches carnitine to fatty acids; allosterically inhibited by malonyl-CoA.

78
New cards

Acyl-Carnitine Translocase

Transporter on the inner mitochondrial membrane that carries acyl-carnitine into the matrix and exports free carnitine.

79
New cards

Carnitine Palmitoyltransferase 2 (CPT2)

Inner mitochondrial matrix enzyme that removes carnitine and attaches CoA back onto the fatty acid for beta-oxidation.

80
New cards

Malonyl-CoA (CPT1 Regulation)

Biosynthetic intermediate whose accumulation allosterically inhibits CPT1, blocking fatty acid entry into the mitochondria and preventing beta-oxidation.

81
New cards

Insulin Dephosphorylation Mechanism

Fed-state signaling where insulin promotes dephosphorylation of metabolic enzymes via downstream protein phosphatases (PP1, PP2, PP4).

82
New cards

Insulin Transcriptional Regulation

Long-term regulation wherein insulin increases transcription of glucokinase, PFK1, and pyruvate kinase, and decreases transcription of G6Pase and PEPCK.

83
New cards

Glucagon Signaling Mechanism

Fasting hormone released during low blood glucose that stimulates phosphorylation of target metabolic enzymes via PKA.

84
New cards

Hexokinase Product Inhibition

Glycolytic enzyme that is allosterically inhibited by its product, glucose-6-phosphate (G6P); turned OFF in a fasted state.

85
New cards

Glucokinase Regulatory Protein (GKRP)

Regulatory protein that sequesters glucokinase upon fructose-6-phosphate buildup and releases glucokinase upon glucose buildup; OFF in fasting.

86
New cards

Phosphofructokinase-1 (PFK1) Regulation

Glycolytic enzyme allosterically activated by F26BP, AMP, and ADP, and allosterically inhibited by ATP and citrate; turned OFF in the fasted state.

87
New cards

Liver Pyruvate Kinase Regulation

Enzyme allosterically activated by F16BP, inhibited by ATP, alanine, and acetyl-CoA, and inactivated by PKA phosphorylation in the liver; OFF in fasting.

88
New cards

Glycogen Synthase Regulation

Enzyme phosphorylated and inhibited by 5 kinases (GSK3, GPK, PKA, CaMK, AMPK); activated by protein phosphatases and allosterically by G6P; OFF in fasting.

89
New cards

Muscle vs. Liver Glycogen Fate

Muscle glycogen is trapped as G6P for local glycolysis and ATP synthesis; liver expresses glucose-6-phosphatase to release free glucose into the blood.

90
New cards

Liver Glycogen Phosphorylase Regulation

Active when phosphorylated by GPK; has no allosteric activators, is allosterically inhibited by glucose, and is deactivated by PP1; ON in fasting.

91
New cards

Muscle Glycogen Phosphorylase Regulation

Activated allosterically by AMP (inhibited form) and inorganic phosphate (Pi, both forms), and allosterically inhibited by G6P; ON in fasting.

92
New cards

Acetylation of Glycogen Phosphorylase

Post-translational modification that attracts PP1 to decrease glycogen phosphorylase activity, signaling that cellular energy needs are met.

93
New cards

Glycogen Phosphorylase Kinase (GPK) Activation

Activated by PKA phosphorylation and maximally active when bound to Ca2+Ca^{2+} (from SR in contracting muscle or smooth ER in liver via epinephrine); ON in fasting.

94
New cards

Adipose Phosphodiesterase (PDE)

Adipose enzyme activated downstream of insulin that converts cAMP to AMP, blocking PKA to turn lipolysis OFF; turned OFF in the fasted state.

95
New cards

Glycerol-3-Phosphate Acyltransferase (GPAT)

Triglyceride synthesis enzyme that is phosphorylated and turned OFF by AMPK in the fasted state.

96
New cards

HMG-CoA Reductase Regulation

Rate-limiting enzyme of cholesterol synthesis that is phosphorylated and turned OFF by AMPK, and allosterically inhibited by cholesterol; OFF in fasting.

97
New cards

Acetyl-CoA Carboxylase (ACC) Regulation

De novo fatty acid synthesis enzyme that is phosphorylated and turned OFF by AMPK in the fasted state.

98
New cards

Malonyl-CoA Decarboxylase (MCD)

Enzyme phosphorylated and turned ON by AMPK that converts malonyl-CoA back to acetyl-CoA, relieving CPT1 inhibition and enabling beta-oxidation.

99
New cards

Fructose 1,6-Bisphosphatase Regulation

Gluconeogenic enzyme that is allosterically inhibited by AMP and fructose-2,6-bisphosphate (F26BPF26BP); turned ON in a prolonged fast.

100
New cards

Saturated Fatty Acid ATP Calculation Formula

Carbons divided by 22 yields acetyl-CoAs (×10 ATP\times 10\text{ ATP}); beta-oxidation cycles equal acetyl-CoAs minus 11 (×4 ATP\times 4\text{ ATP} from 1 FADH2+1 NADH1\text{ FADH}_2 + 1\text{ NADH}); sum gross ATP and subtract 2 ATP2\text{ ATP} used for activation.